Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             52 results found
no title author magazine year volume issue page(s) type
1 A Cancer in the Family Harding, Emilia
 2016
 17 10 p. 1359-
1 p.
 article
2 Access to loan-related insurance for French cancer survivors Dumas, Agnès
 2016
 17 10 p. 1354-1356
3 p.
 article
3 An antidote to fluorouracil and capecitabine toxicity Wilkinson, Emma
 2016
 17 10 p. e429-
1 p.
 article
4 Antiemetic overuse in patients receiving chemotherapy Das, Manjulika
 2016
 17 10 p. e428-
1 p.
 article
5 Arginine deprivation for ASS1-deficient mesothelioma Burki, Talha Khan
 2016
 17 10 p. e423-
1 p.
 article
6 Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: a multicentre, single-group, open-label, phase 2 trial Kaufman, Howard L
 2016
 17 10 p. 1374-1385
12 p.
 article
7 Be Here Now Zajanckauskaite, Estera
 2016
 17 10 p. 1361-
1 p.
 article
8 Cancer in patients with inherited ciliopathies: polycystic kidney disease Chapman, Jeremy R
 2016
 17 10 p. 1343-1345
3 p.
 article
9 Cancer of unknown primary: time to put the pieces of the puzzle together? Economopoulou, Panagiota
 2016
 17 10 p. 1339-1340
2 p.
 article
10 Cancer-related fatigue in patients with and survivors of Hodgkin's lymphoma: a longitudinal study of the German Hodgkin Study Group Kreissl, Stefanie
 2016
 17 10 p. 1453-1462
10 p.
 article
11 Carfilzomib therapy improves quality of life in multiple myeloma Das, Manjulika
 2016
 17 10 p. e427-
1 p.
 article
12 Checkpoint inhibitors: a new standard of care for advanced Merkel cell carcinoma? Hauschild, Axel
 2016
 17 10 p. 1337-1339
3 p.
 article
13 Colorectal cancer trial endpoints: time for dynamic thinking? Davidson, Michael
 2016
 17 10 p. 1345-1347
3 p.
 article
14 Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial Marina, Neyssa M
 2016
 17 10 p. 1396-1408
13 p.
 article
15 Cord blood transplant improves outcomes in leukaemia Brower, Vicki
 2016
 17 10 p. e425-
1 p.
 article
16 Correction to Lancet Oncol 2016; 17: 738 2016
 17 10 p. e420-
1 p.
 article
17 Correction to Lancet Oncol 2016; 17: 1426 2016
 17 10 p. e420-
1 p.
 article
18 Correction to Lancet Oncol 2016; 17: 1203, 06, 08, 09, 11 2016
 17 10 p. e420-
1 p.
 article
19 Correction to Lancet Oncol 2016; 17: e310 2016
 17 10 p. e420-
1 p.
 article
20 Correction to Lancet Oncol 2016; 17: e423 2016
 17 10 p. e420-
1 p.
 article
21 Daratumumab combination prolongs myeloma survival Das, Manjulika
 2016
 17 10 p. e422-
1 p.
 article
22 De-escalation of axillary surgery in early breast cancer Jatoi, Ismail
 2016
 17 10 p. e430-e441
nvt p.
 article
23 Does persistent fatigue in survivors relate to cancer? Henry-Amar, Michel
 2016
 17 10 p. 1351-1352
2 p.
 article
24 Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis Moran, Sebastian
 2016
 17 10 p. 1386-1395
10 p.
 article
25 FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab for metastatic colorectal cancer (FIRE-3): a post-hoc analysis of tumour dynamics in the final RAS wild-type subgroup of this randomised open-label phase 3 trial Stintzing, Sebastian
 2016
 17 10 p. 1426-1434
9 p.
 article
26 Genome-wide association studies in oesophageal adenocarcinoma and Barrett's oesophagus: a large-scale meta-analysis Gharahkhani, Puya
 2016
 17 10 p. 1363-1373
11 p.
 article
27 HSD3B1 and resistance to androgen-deprivation therapy in prostate cancer: a retrospective, multicohort study Hearn, Jason W D
 2016
 17 10 p. 1435-1444
10 p.
 article
28 Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study O'Brien, Susan
 2016
 17 10 p. 1409-1418
10 p.
 article
29 Ibrutinib holds promise for patients with 17p deletion CLL Ghia, Paolo
 2016
 17 10 p. 1342-1343
2 p.
 article
30 I have no time for cancer Morgan, Jules
 2016
 17 10 p. 1360-
1 p.
 article
31 Improving cervical cancer screening in Baltic, central, and eastern European countries Altobelli, Emma
 2016
 17 10 p. 1349-1350
2 p.
 article
32 Incorrect catheter placement for drainage of malignant pericardial effusion Muršić, Davorka
 2016
 17 10 p. e467-
1 p.
 article
33 Inherited HSD3B1 polymorphisms and hormonal therapy resistance Antonarakis, Emmanuel S
 2016
 17 10 p. 1347-1349
3 p.
 article
34 International clinical practice guidelines including guidance for direct oral anticoagulants in the treatment and prophylaxis of venous thromboembolism in patients with cancer Farge, Dominique
 2016
 17 10 p. e452-e466
nvt p.
 article
35 Leaky transporters and sphincters in Barrett's oesophagus? Meltzer, Stephen J
 2016
 17 10 p. 1336-1337
2 p.
 article
36 Making paediatric precision oncology a reality The Lancet Oncology,
 2016
 17 10 p. 1335-
1 p.
 article
37 Maximum benefit of chemotherapy for osteosarcoma achieved—what are the next steps? Kleinerman, Eugenie
 2016
 17 10 p. 1340-1342
3 p.
 article
38 Melanoma screening by non-health-care professionals Pleat, Jonathon
 2016
 17 10 p. 1352-1353
2 p.
 article
39 Mutational subgroups for oesophageal adenocarcinoma Burki, Talha Khan
 2016
 17 10 p. e426-
1 p.
 article
40 NICE guidance on ramucirumab for previously treated locally advanced or metastatic non-small-cell lung cancer Hall, Caroline J
 2016
 17 10 p. 1357-1358
2 p.
 article
41 Paintfest America Kinsey, Caroline
 2016
 17 10 p. 1362-
1 p.
 article
42 PCI in resected small-cell lung cancer Knisely, Jonathan
 2016
 17 10 p. e415-
1 p.
 article
43 PCI in resected small-cell lung cancer – Author's reply Le Péchoux, Cécile
 2016
 17 10 p. e416-
1 p.
 article
44 Predicting lung cancer prognosis using machine learning Burki, Talha Khan
 2016
 17 10 p. e421-
1 p.
 article
45 Preventable fractions of cervical cancer via effective screening in six Baltic, central, and eastern European countries 2017–40: a population-based study Vaccarella, Salvatore
 2016
 17 10 p. 1445-1452
8 p.
 article
46 Prophylactic radiotherapy to prevent procedure-tract metastases Zalcman, G
 2016
 17 10 p. e417-
1 p.
 article
47 Prophylactic radiotherapy to prevent procedure-tract metastases Landau, David
 2016
 17 10 p. e418-
1 p.
 article
48 Prophylactic radiotherapy to prevent procedure-tract metastases – Author's reply Clive, Amelia O
 2016
 17 10 p. e419-
1 p.
 article
49 Risk of cancer in patients with polycystic kidney disease: a propensity-score matched analysis of a nationwide, population-based cohort study Yu, Tung-Min
 2016
 17 10 p. 1419-1425
7 p.
 article
50 Sharks Get Cancer, Mole Rats Don't Denny, Victoria
 2016
 17 10 p. 1359-
1 p.
 article
51 Sorafenib plus cisplatin for hepatocellular carcinoma Brower, Vicki
 2016
 17 10 p. e424-
1 p.
 article
52 Treatment of low-risk ductal carcinoma in situ: is nothing better than something? Benson, John R
 2016
 17 10 p. e442-e451
nvt p.
 article
                             52 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands